Osteopathic Center
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
Miami, FL
Stem cell therapy marketing in Miami spans orthopedic injectables, regenerative suites, and cash-pay longevity clinics across Brickell, Coral Gables spillover, Coconut Grove corridors, and Miami Beach filters that still map under Miami. "Stem cell" on a menu can mean autologous concentrates, adipose-derived products, or offerings that blur into PRP. Humidity and tourist scheduling change logistics, not product quality.
This hub lists Directory clinics for Miami and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask tissue source, processing method, who performs the procedure, how regulatory status is described, and what follow-up they track. Prefer written protocols over beach-wellness lifestyle ads.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Florida cellular therapy providers are governed by 21 CFR Part 1271. Section 361 applies to minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 applies to products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND or BLA. Most stem cell, stromal vascular fraction, exosome, umbilical cord blood derived, and culture-expanded mesenchymal cell therapies marketed in Florida for orthopedic, neurologic, autoimmune, and longevity indications fall under Section 351 and lack FDA approval. Florida is a high-volume market, which has translated into elevated federal scrutiny.
Florida has been a primary target of FDA enforcement. In US v US Stem Cell Inc (2019), a federal court in Florida granted a permanent injunction against a Sunrise-based clinic for marketing unapproved stem cell products derived from adipose tissue. The Eleventh Circuit upheld the injunction in 2021. The FDA has issued multiple warning letters to Florida clinics offering exosome and umbilical cord-derived therapies. The Florida Department of Health and the Boards of Medicine and Osteopathic Medicine have disciplined physicians for unprofessional conduct tied to misleading regenerative medicine marketing. The Florida Attorney General has pursued deceptive trade practice claims under FDUTPA against stem cell clinics.
Available here
Nationwide
Stem Cell Therapy clinics across the US